Inspire Medical Systems, Inc. (INSP)

Inspire Medical Systems Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	145.42	53.51	-21.15	-44.88	-42.04
Depreciation & Amortization	13.96	6.55	2.85	1.86	1.22
Loss (Gain) From Sale of Investments	-2.89	-8.86	-2.47	-0	0.01
Stock-Based Compensation	130.26	116.01	82.47	51.97	26.48
Provision & Write-off of Bad Debts	0.2	-0.77	1.61	-0.06	-
Other Operating Activities	-82.59	1.52	2.13	0.88	1.07
Change in Accounts Receivable	-26.23	-2.6	-30.22	-27.02	-9.24
Change in Inventory	-65.18	-46.23	-22	5.35	-8.75
Change in Accounts Payable	-3.75	0.6	9.3	14.36	4.78
Change in Other Net Operating Assets	7.77	10.52	2.14	9.13	6.36
Operating Cash Flow	116.98	130.25	24.65	11.57	-20.12
Operating Cash Flow Growth	-10.19%	428.32%	113.09%	-	-
Capital Expenditures	-38.5	-39.12	-23.63	-9.1	-4.67
Investment in Securities	59.95	-74	-271.19	-10.5	33.81
Investing Cash Flow	21.45	-113.12	-294.82	-19.6	29.14
Long-Term Debt Repaid	-	-	-	-24.5	-
Net Debt Issued (Repaid)	-	-	-	-24.5	-
Issuance of Common Stock	14.61	27.77	31.11	259.62	14.95
Repurchase of Common Stock	-198.06	-80.17	-17.16	-0.04	-
Financing Cash Flow	-183.45	-52.39	13.95	235.08	14.95
Foreign Exchange Rate Adjustments	-0.31	-0.12	0.16	0.08	-0.02
Net Cash Flow	-45.34	-35.39	-256.06	227.13	23.95
Free Cash Flow	78.48	91.12	1.02	2.47	-24.79
Free Cash Flow Growth	-13.88%	8798.73%	-58.59%	-	-
Free Cash Flow Margin	8.61%	11.35%	0.16%	0.61%	-10.62%
Free Cash Flow Per Share	2.64	2.98	0.04	0.09	-0.91
Cash Interest Paid	0.14	0.02	-	2.32	1.89
Levered Free Cash Flow	54.5	62.72	0.03	17.43	-10.69
Unlevered Free Cash Flow	54.59	62.73	0.03	18.48	-9.36
Change in Working Capital	-87.38	-37.71	-40.78	1.81	-6.86

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q